Altogether, this study suggests that REV7 is increased in glioma tissues and REV7 sensitized cisplatin via the modulation of the PI3K/AKT signaling pathway, thereby mediating cell proliferation and apoptosis in vitro. The gene discussed is MAD2L2; the disease is central nervous system cancer.